Reduced Bik Expression Drives Low-Grade Airway Inflammation and Increased Risk for COPD in Females
Source : https://pubmed.ncbi.nlm.nih.gov/38357926/
Chronic low-grade inflammation is increasingly recognized as a subtle yet potent risk factor for a multitude of age-related disorders, including respiratory diseases, cardiovascular conditions, metabolic syndromes, autoimmunity, and cancer. In...
The therapeutic potential of transgenic Bik expression in mitigating allergen or LPS-induced lung inflammation and reversing emphysema in female mice could pave the way for novel treatments targeting low-grade inflammation.
Bronchoscopic Lung Volume Reduction by Instillation of Fibrinogen and Thrombin in COPD Patients With Homogenous Emphysema
Source : https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-024-02883-4
Background The new endobronchial therapy called biological lung volume reduction (BioLVR) involves using a rapid polymerizing sealant to block off the most emphysematous portions of the lungs. The primary mechanism...
There was a reduction in lung volume at the first, third, and sixth month postoperatively determined by HRCT volumetry and RV/TLC (percent predicted).
Exploring the Novel Duo of Reticulocalbin, and Sideroflexin as Future Biomarker Candidates for Exacerbated Chronic Obstructive Pulmonary Disease
Source : https://clinicalproteomicsjournal.biomedcentral.com/articles/10.1186/s12014-024-09459-8
Background COPD is a complex respiratory disorder with high morbidity and mortality rates. Even with the current conventional diagnostic methods, including circulating inflammatory biomarkers, underdiagnosis rates in COPD remain as...
The present study discovered a novel protein duo, reticulocalbin-1 and sideroflexin-4, making a breakthrough in understanding the downstream signaling in exacerbation COPD thereby leading to improved clinical management of the disease.
The Application of Nanoparticles as Advanced Drug Delivery Systems in Attenuating COPD
Source : https://pubmed.ncbi.nlm.nih.gov/38356590/
Chronic Obstructive Pulmonary Disease (COPD) is a dilapidating condition which is characterized by inflammation, an excess in free radical generation and airway obstruction. Currently, the drugs commercially available for the...
Nanotechnology has proven to be highly desirable in its ability to create novel and advanced drug delivery systems which enable an elevated level of precision when delivering the drug to the target site.
A Machine Learning Model for Predicting Acute Exacerbation of In-Home Chronic Obstructive Pulmonary Disease Patients
Source : https://pubmed.ncbi.nlm.nih.gov/38354578/
The tree-based boosting models prove to be effective in predicting AECOPD events in our study. Consequently, these models have the potential to enhance remote monitoring, enable early risk assessment, and...
Using the collected data, researchers developed an effective model for predicting the onset of the Acute Exacerbation of Chronic Obstructive Pulmonary Disease tool using machine learning algorithms.